Quote:

---

no clue how long it takes to analyze the data for a mouse study

---

In the May CC Dr Jay said results would be available "in the fall."

Meanwhile, looking at the language he used about the study then makes it clear that 1) CYDY contracted with the lab, not Madrigal/CYDY or Madrigal alone, and 2) we do not have a partnership, but are free to partner with anyone. If Leron + Resme are the best results, it would make sense to partner with Madrigal, but if Leron alone is just as good, any BP would love to snatch a piece of Madrigal's pie.

Quote:

---

We have contracted with the lab to perform a pre-clinical mouse study, evaluating both 350 and 700, milligram dose levels alone, and in combination with Resmetirom, a drug recently approved by the FDA for the treatment of mash.

The study will evaluate Leronlimab with, and without Resmetirom in both preventing, as well as reversing liver fibrosis. The results of this study should be available in the fall and will, hopefully then enable us to pursue Partnerships evaluating combination therapy in the math space.

---

Quote:

---

---